Considerations for Endpoints in Lung Transplant Clinical Trials: An ISHLT Consensus Statement

By afschroeder • December 17, 2025

Greenland JR, Perch M, Halloran K, Levine DJ, Morrell ED, Reed A, Shaver CM, Singer JP, Sweet SC, Vos R, Aryal S, Avdimiretz N, Burrows F, Calabrese D, Calabrese F, Campos S, Combs M, de Perrot M, Dellgren G, Diamond JM, Egan T, Ging P, Glidden DV, Goddard M, Jyothula S, Keller M, Kulkarni H, Kwakkel-van Erp JM, Lama V, Marczin N, Martinu T, Neely ML, Palmer SM, Patterson CM, Pavlisko EN, Pham C, Sanchez M, Schultz HHL, Schwerk N, Shah U, Shashaty M, Singer L, Smith P, Snyder LD, Solomon M, Verleden S, Verplancke V, Zeevi A, Todd JL. Considerations for Endpoints in Lung Transplant Clinical Trials: An ISHLT Consensus Statement. J Heart Lung Transplant. 2025 Nov 14:S1053-2498(25)02283-1. doi: 10.1016/j.healun.2025.09.017. Epub ahead of print. PMID: 41400593.

Tags: acute cellular rejection, Antibody mediated rejection, chronic lung allograft dysfunction, clinical trials, Endpoints, Lung transplantation, Primary Graft Dysfunction, Publications, Pulmonary, Critical Care & Sleep Medicine

The Next Chapter of Cancer Immunology Research

Jaffee EM, Ribas A. The Next Chapter of Cancer Immunology Research. Cancer Immunol Res. 2026 Jan 8;14(1):8-9. doi: 10.1158/2326-6066.CIR-25-1391. PMID: 41502310.

PenA Alleles Associated With Gonococcal Ceftriaxone Resistance in Cambodia, China, and Vietnam

van der Veen S, Sun X, Ge H, Chau TM, Nhung PH, Vandelannoote K, Delvallez G, Cheng S, Laumen JGE, Adamson PC. PenA Alleles Associated[...]

Cefixime for the Treatment of Neisseria gonorrhoeae Infections in a Setting With Increased Antimicrobial Resistance: A Retrospective Study in Hanoi, Vietnam

Adamson PC, David HM, Pham LQ, Bui HTM, Le HHL, Pham QH, Le DH, Giang LM, Klausner JD. Cefixime for the Treatment of Neisseria gonorrhoeae[...]